06 jun: Egypt Orascom Telecom CEO: $1.3 Billion Algeria Fine Dispute Seen..
06 jun: Treasury's Geithner: Urges 'All Responsible Cou..
06-06-2012 15:31:00

WSJ BLOG/Health: A.M. Vitals: J & J To Stop Selling Surgical Mesh

Relateret indhold

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Amy Dockser Marcus

Here's what's happening in health news this morning:

J&J To Stop Selling Surgical Mesh (WSJ): Johnson & Johnson says it will stop selling its version of a surgical mesh product used to treat a painful pelvic condition in women.

Sex Bug Growing Resistant to Drugs, WHO Warns (AP): Gonorrhea, a sexually transmitted disease that infects millions, is growing resistant to drugs, raising worries among health officials that in a few years, it could become untreatable.

FDA Rejects Merck's Treatment for Bone Cancer (WSJ): The FDA rejected a new drug application for ridaforolimus, a bone cancer treatment, saying further trials are needed to assess the drug's effectiveness and safety.

Depressed? Treatment May Be A Phone Call Away (NPR Shots): Researchers at Northwestern University Feinberg School of Medicine found that people with major depression who received 18 weeks of talk therapy over the phone showed similar improvement to those who received the therapy in person, according to a study published in the Journal of the American Medical Association.

Exercise Benefits Black Girls Less Than Whites, Study Shows (LA Times): A study published in the Archives of Pediatrics and Adolescent Medicine compared white and black girls' physical activity and food intake and found that black adolescent girls don't appear to benefit as much from the effects of physical activity in preventing obesity as white peers.

-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

(END) Dow Jones Newswires

June 06, 2012 09:31 ET (13:31 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Mærsk annoncerer rateløft på Asien - Europa

22-07-2014 15:21:04
A.P. Møller - Mærsks containerdivision er atter på vej med ratestigninger på den vigtige fart mellem Asien og Nordeuropa. I ugebrevet "Weekly Highlights" fortæl..

Dupont leverede som ventet i andet kvartal

22-07-2014 12:13:47
Amerikanske Dupont, der i 2011 købte Danisco, leverede i sit andet kvartal et resultat ganske som ventet, mens omsætningen skuffede en smule. Selskabet nedjuste..

Aktier/middag: Markedet tager atter risiko ind på bøgerne

22-07-2014 11:29:52
Risikoknappen er atter drejet over på "on" på aktiehandlernes styrepulte, og det gælder også på det danske aktiemarked, der atter er over indeks 800, målt på C2..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/Sydbank: Plads til stigninger, men ikke til skuffelser
2
Aktier/tendens: Plus i sigte inden regnskabets time
3
Vestas vender tilbage til Indien efter to års fravær - medie
4
Novos kombinationsprodukt nærmer sig eksamen hos EMA
5
Apple får tæsk af miniput i Kina - avis

Relaterede aktiekurser

Johnson & Johnson 102,47 1,2% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. juli 2014 01:18:39
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140710.1 - EUROWEB5 - 2014-07-23 01:18:39 - 2014-07-23 01:18:39 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x